The evidence review
Reviewed by Dr Ron Goedeke · Every claim sourced inline · Last checked June 2026
01 · The evidence
Skin
Eyes
Joints
Park (2010) Park 2010 showed reductions in C-reactive protein and other inflammatory markers in healthy adults, and the wider mechanism review Fakhri 2018 maps the anti-inflammatory action onto TNF-alpha, IL-6 and NF-kB, the same pathways NSAIDs target. The practical difference from NSAIDs is that astaxanthin doesn’t damage the stomach lining, so it suits long-term use. The trade is speed: NSAIDs work in hours, astaxanthin over weeks. Direct joint-pain trials are still limited, which keeps this in the moderate-evidence column.
Heart and circulation
Brain
02 · Emerging areas
Lower post-exercise muscle-damage markers and faster recovery in endurance athletes, usually at 4 mg a day for four weeks before an event.
Better sperm motility and less DNA fragmentation in men with subfertility, in trials around 16 mg a day for three months.
Secondary gains in skin, mood and metabolic markers in women already supplementing for other reasons. No dedicated menopause trials yet.
Reports of easier sleep onset and depth, possibly through the retina's role in circadian rhythm or lower inflammation. Trial evidence is thin.
Lower liver enzymes in small open-label trials in fatty liver disease.
03 · Where it's weaker
04 · Who it's for
05 · Stacking
In short
Medically reviewed